Mariken van der Lubben

Author

National Institute for Public Health and the Environment

Also Known As

M van der Lubben, M. van der Lubben, Mariken Van der Lubben, Mariken van der Lubben, Van Der Lubben, M.

Publications

420

Citations

H-Index

Concepts

All Affiliations

National Institute for Public Health and the Environment GGD Amsterdam Amsterdam University Medical Centers University Medical Center Utrecht Utrecht University

About

Mariken van der Lubben is an author at National Institute for Public Health and the Environment specializing in medicine, epidemiology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	118
2	Epidemiology	5	5	97
3	Public Health	2	2	25
4	Engineering	1	1	21
5	Biostatistics	1	1	21

Mariken van der Lubben

Publications

394

Citations

H-Index

Page 1

	Year	Citations
Pathogenic characteristics of persistent feline enteric coronavirus infection in cats L Vogel, Mariken van der Lubben, Eddie G. te Lintelo, Veterinary Research	2010	109
Age-Dependent Patterns of Infection and Severity Explaining the Low Impact of 2009 Influenza A (H1N1): Evidence From Serial Serologic Surveys in the Netherlands Anneke Steens, Sandra Waaijenborg, Peter Teunis, American Journal of Epidemiology	2011	92
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009–2010 Adam Meijer, Marcel Jonges, Floor Abbink, Antiviral Research Infectious Disease EpidemiologyEpidemic IntelligencePathogen PrevalenceVirus EpidemiologyVirology	2011	35
Hospitalisation rates differed by city district and ethnicity during the first wave of COVID-19 in Amsterdam, The Netherlands Liza Coyer, Elke Wynberg, Marcel Buster, BMC Public Health	2021	32
Transmission of Novel Influenza A(H1N1) in Households with Post-Exposure Antiviral Prophylaxis Michiel van Boven, Tjibbe Donker, Mariken van der Lubben, PLoS ONE	2010	30
HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains Willem Luytjes, Vincent Enouf, Maarten Schipper, Vaccine VaccinationCross-protectionVaccine DevelopmentHi ResponsesImmunology	2012	23
Ruling out SARS-CoV-2 infection using exhaled breath analysis by electronic nose in a public health setting Rianne de Vries, René M. Vigeveno, Simone Mulder, EngineeringCovid-19Diagnostic TestRespiratory InfectionBiostatistics	2021	21
Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks Liselotte van Asten, Mariken van der Lubben, Cees van den Wijngaard, Journal of Clinical Virology Virus EpidemiologyViral DiagnosticsRespiratory InfectionDiagnostic CapacityVirology	2009	14
Epidemiologic and Genomic Analysis of SARS-CoV-2 Delta Variant Superspreading Event in Nightclub, the Netherlands, June 2021 Jelle Koopsen, Catharina E van Ewijk, Roisin Bavalia, Emerging infectious diseases VaccinationRapid DisseminationJune 2021Virus EpidemiologyEmerging Infectious Diseases	2022	14
National point prevalence study on carriage of multidrug-resistant microorganisms in Dutch long-term care facilities in 2018 Esther van Kleef, Cornelia C. H. Wielders, Leo M. Schouls, Journal of Antimicrobial Chemotherapy	2021	13

Page 1